Every 43 seconds someone in the US has a heart attack and every four minutes, an American dies from a stroke. Very often people who suffer these events were previously unaware that they had cardiovascular disease (CVD), the leading killer of both men and women in the US.
Beside the usual LDL and HDL cholesterol assessment, Dr. Sierra's approach includes many more advanced serum markers for CVD risk (such as insulin, hemoglobin A1C, apo-proteins, homocysteine, C-reactive protein, fibrinogen, lp-plac test, and many more.) These tests for future CVD risk measure arterial inflammation, metabolic syndrome, insulin resistance, blood clotting tendency, and genetic determinants.
Dr. Sierra uses the Bale-Doneen Method, a well publicized methodology developed by two physicians in the book called, Beat the Heart Attack Gene, of utmost importance is her patient's family history and metabolic make-up. While many cardiologists and primary care physicians focus just on lowering LDL cholesterol levels with statin drugs, there are so many other lab tests that help elicit the risks that a patient has yet to overcome.
All of these test findings, above and more, play into the suggestions Dr. Sierra makes for certain pharmaceutical, nutraceutical, dietary and exercise interventions. Reassessments are done periodically to ascertain declining risk.